(CON) Concentra Holdings Parent - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock •
CON: Health, Services, Care, Testing, Pharmacy, Wellness
Concentra Group Holdings Parent, Inc. (NYSE:CON) is a leading provider of occupational health services in the United States, focusing on delivering comprehensive healthcare solutions tailored for employers and employees. Their extensive range of services includes workers compensation injury care, urgent care, clinical testing, and preventative care programs, all designed to optimize workplace health and productivity.
The company stands out with its innovative telemedicine solution, Concentra Telemed, which offers remote consultations for work-related injuries and illnesses. This service not only enhances accessibility for employees but also streamlines healthcare delivery for employers, reducing downtime and associated costs. Additionally, Concentra provides pharmacy solutions under the Concentra Pharmacy name and compliance administration services, aiding employers in managing drug-testing programs efficiently, whether for regulated or non-regulated workforces.
As a subsidiary of Select Medical Corporation, Concentra benefits from the resources and expertise of one of the largest rehabilitation providers in the country. This affiliation underscores Concentras commitment to high-quality patient care and operational excellence, positioning it as a trusted partner in occupational health.
Financially, Concentra demonstrates robust market presence with a market capitalization of approximately $2.9 billion, reflecting its established position in the healthcare sector. The current P/E ratio of 22.67, coupled with a forward P/E of 18.05, suggests investor confidence and anticipated growth. A P/B ratio of 2.35 indicates a premium valuation relative to book value, while the P/S ratio of 1.57 highlights moderate revenue efficiency.
Headquartered in Mechanicsburg, Pennsylvania, and founded in 1979, Concentra has built a legacy of providing integrated occupational health solutions. Their approach not only addresses immediate healthcare needs but also emphasizes preventative measures and compliance, making them a holistic partner for employers seeking to foster a healthier, safer workforce. For more information, visit their website at https://www.concent
Additional Sources for CON Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CON Stock Overview
Market Cap in USD | 2,927m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2024-07-25 |
CON Stock Ratings
Growth 5y | -22.4% |
Fundamental | 20.1% |
Dividend | 7.60% |
Rel. Strength Industry | -5.33 |
Analysts | 4.63/5 |
Fair Price Momentum | 19.24 USD |
Fair Price DCF | 38.40 USD |
CON Dividends
Dividend Yield 12m | 0.29% |
Yield on Cost 5y | 0.28% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
CON Growth Ratios
Growth Correlation 3m | 55.7% |
Growth Correlation 12m | -16.4% |
Growth Correlation 5y | -16.4% |
CAGR 5y | -7.23% |
CAGR/Max DD 5y | -0.35 |
Sharpe Ratio 12m | -0.79 |
Alpha | -13.77 |
Beta | 0.36 |
Volatility | 34.21% |
Current Volume | 706.1k |
Average Volume 20d | 797.5k |
As of March 15, 2025, the stock is trading at USD 20.79 with a total of 706,139 shares traded.
Over the past week, the price has changed by -6.48%, over one month by -8.49%, over three months by -2.21% and over the past year by -7.23%.
Neither. Based on ValueRay Fundamental Analyses, Concentra Holdings Parent is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.09 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CON as of March 2025 is 19.24. This means that CON is currently overvalued and has a potential downside of -7.46%.
Concentra Holdings Parent has received a consensus analysts rating of 4.63. Therefor, it is recommend to buy CON.
- Strong Buy: 5
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CON Concentra Holdings Parent will be worth about 20.8 in March 2026. The stock is currently trading at 20.79. This means that the stock has a potential downside of -0.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 29.8 | 43.3% |
Analysts Target Price | 29.8 | 43.3% |
ValueRay Target Price | 20.8 | -0.1% |